Request Consultation
Woman performing supervised resistance training during a physician-led weight-loss program

On a GLP-1 After 40? The Scale Cannot Tell You Whether You Are Becoming Healthier

Metabolic Health

By Dr. Swara Afiniwala, MD
A woman can lose 25 pounds and improve her blood pressure, glucose, and visceral fat. She can also lose muscle,
strength, facial volume, and bone-supporting tissue. Both can happen at the same time.
That is why medically supervised weight loss after 40 should not be judged by the scale alone. The more important
question is: What did you lose, and what did you preserve?

Midlife weight loss is different for women

Women are not smaller versions of men. During perimenopause and menopause, declining estrogen affects insulin
sensitivity, fat distribution, bone remodeling, and muscle protein turnover. In the longitudinal Study of Women’s
Health Across the Nation, fat gain accelerated and lean mass declined beginning about two years before the final
menstrual period, even though body weight did not change as abruptly. This helps explain why many women say,
“My weight is similar, but my body is different.”
A plan built around severe calorie restriction and more cardio can magnify that change. Midlife nutrition must provide
enough energy, protein, fiber, essential fats, and micronutrients while accounting for appetite suppression, activity,
menopausal stage, medical conditions, and bone health. This is not a rigid “female diet.” It is a prescription based on
female physiology and the tissue we are trying to preserve.
Older muscle becomes less responsive to small protein doses, a phenomenon called anabolic resistance. Protein
quantity, quality, and distribution across meals matter. Targets should be individualized, particularly in kidney
disease.

Resistance training is metabolic medicine

Walking supports cardiovascular health, but it does not replace progressive resistance training when the goal is to
preserve muscle. Resistance training means repeatedly challenging muscle with increasing load. Examples include
squats or leg presses, hinges or deadlifts, rows, presses, loaded carries, and step-ups, adapted to the patient’
mobility and joint health.
Contracting muscle moves GLUT4 glucose transporters to the cell surface, allowing glucose uptake through a
pathway partly independent of insulin. Repeated training increases GLUT4 expression, insulin signaling,
mitochondrial capacity, and glycogen storage. A larger, better-trained muscle compartment gives the body a more
effective place to dispose of glucose after meals and can improve peripheral insulin sensitivity for up to 48 hours
after exercise.
Resistance training also improves strength, balance, tendon capacity, and the mechanical loading needed to support
bone. In the Health ABC Study of 2,292 older adults, grip and quadriceps strength predicted mortality more strongly
than muscle mass alone. Strength is not merely a fitness metric. It is a marker of physiologic reserve.
Current guidance recommends training all major muscle groups at least twice weekly. The correct load, volume, and
progression depend on training history, balance, recovery, cardiovascular status, and injury risk.

GLP-1 weight loss can include lean tissue

GLP-1 weight loss can include lean tissue
GLP-1 medications can meaningfully improve obesity and cardiometabolic risk. They are valuable tools when
appropriately prescribed. But faster loss is not automatically better loss.
ATLAS LIFESPAN | WEB DEVELOPMENT HANDOFF Page 2 of 13
In the STEP 1 body-composition substudy, semaglutide reduced body weight by 15 percent, total fat mass by 19.3
percent, and regional visceral fat by 27.4 percent over 68 weeks. Lean body mass also fell by 9.7 percent. Fat loss
predominated, but the absolute lean-tissue loss remained clinically relevant.
Appetite suppression can compromise protein, fluids, and micronutrients. Rapid loss from any cause can increase
gallstone risk and trigger temporary hair shedding through telogen effluvium. Loss of facial and subcutaneous fat can
create hollowing, loose skin, and more visible folds. These changes are sometimes called “Ozempic face,” but
evidence does not establish unique facial toxicity from semaglutide. The speed and magnitude of loss, age, skin
elasticity, smoking, sun exposure, and nutrition all contribute.

Measure the tissue, not just the pounds

InBody and DEXA answer different questions. InBody uses bioelectrical impedance and is useful for frequent trend
monitoring, but hydration, meals, exercise, and time of day can shift its estimates. Repeat scans should use similar
conditions.
DEXA offers a more detailed assessment of regional fat and lean mass and can evaluate bone density when
clinically indicated. Neither test measures muscle quality or function. Results belong beside waist circumference,
strength, symptoms, dietary intake, and medical risk.
The endpoint is not the lowest possible weight. It is less visceral fat, preserved muscle and bone, better insulin
sensitivity, and a body that remains strong, capable, and recognizably yours.
Ready for personalized care? Book a discovery call with Atlas Lifespan.

Clinical references

  1. Greendale GA, et al. JCI Insight. 2019;4(5):e124865. https://pubmed.ncbi.nlm.nih.gov/30843880/
  2. Newman AB, et al. J Gerontol A Biol Sci Med Sci. 2006;61(1):72-77. https://pubmed.ncbi.nlm.nih.gov/
    16456196/
  3. Wilding JPH, et al. STEP 1 body-composition analysis. J Endocr Soc. 2021. https://pmc.ncbi.nlm.nih.gov/
    articles/PMC8089287/
  4. Sims ST, et al. Female athlete nutrition position stand. J Int Soc Sports Nutr. 2023;20(1):2204066. https://
    pmc.ncbi.nlm.nih.gov/articles/PMC10210857/
  5. American College of Sports Medicine. Resistance training guidance. https://acsm.org/resistance-trainingguidelines-update-2026
  6. Endotext. The role of exercise in diabetes and glucose metabolism. https://www.ncbi.nlm.nih.gov/books/
    NBK549946/ ↩︎